SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017100
Filing Date
2019-11-14
Accepted
2019-11-13 21:58:26
Documents
51
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 965180
2 ex10-5.htm EX-10.5 27936
3 ex10-5_001.jpg GRAPHIC 12241
4 ex31-1.htm EX-31.1 8849
5 ex31-2.htm EX-31.2 8713
6 ex32-1.htm EX-32.1 6801
  Complete submission text file 0001493152-19-017100.txt   3106589

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rttr-20190930.xml EX-101.INS 401837
8 XBRL SCHEMA FILE rttr-20190930.xsd EX-101.SCH 28361
9 XBRL CALCULATION FILE rttr-20190930_cal.xml EX-101.CAL 41815
10 XBRL DEFINITION FILE rttr-20190930_def.xml EX-101.DEF 121160
11 XBRL LABEL FILE rttr-20190930_lab.xml EX-101.LAB 239727
12 XBRL PRESENTATION FILE rttr-20190930_pre.xml EX-101.PRE 193817
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 191216102
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences